Domestic pharmaceutical firms urged to nurture non-flagship products

Published: 2004-05-17 07:00:00

Updated: 2004-05-17 07:00:00

Major domestic pharmaceutical firms have relied heavily on flagship products to achieve their sales target amid protracted business slump, but market analysts say that there is an urgent need to cultivate non-flagship products to cushion the lackluster sales of these products that might affect the overall management in terms of profitability and safety.

According to data released by Yakup Sh...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.